Also, a malaria pre-clinical study found that the combination of protein in adjuvant with viral vectors in both priming and boosting vaccinations could induce extremely high antibody titres and CD4+ T-cell and CD8+ T-cell responses [34]. The gene discussed is CD8A; the disease is malaria.